|
|
Volumn 291, Issue 5504, 2001, Pages 581-582
|
|
Anti-inflammatories inhibit cancer growth - But how?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
BCL2L1 PROTEIN, HUMAN;
CELL RECEPTOR;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTEIN BCL 2;
PROTEIN BCL X;
PTGS2 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
CANCER CENTER;
CANCER INHIBITION;
CANCER PREVENTION;
DRUG MECHANISM;
ENZYME INHIBITION;
FAMILIAL POLYPOSIS;
GASTROINTESTINAL DISEASE;
HUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
APOPTOSIS;
ARTICLE;
CLINICAL TRIAL;
COLON POLYPOSIS;
DRUG EFFECT;
ENZYMOLOGY;
GENETICS;
METABOLISM;
NEOPLASM;
TUMOR SUPPRESSOR GENE;
ADENOMATOUS POLYPOSIS COLI;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BCL-X PROTEIN;
CLINICAL TRIALS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
GENES, APC;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
NEOPLASMS;
NF-KAPPA B;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
TRANSCRIPTION FACTORS;
|
|
EID: 0035951493
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.291.5504.581 Document Type: Short Survey |
|
Times cited : (102)
|
|
References (0)
|